| pubmed-article:11355109 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11355109 | lifeskim:mentions | umls-concept:C0027763 | lld:lifeskim |
| pubmed-article:11355109 | lifeskim:mentions | umls-concept:C0598958 | lld:lifeskim |
| pubmed-article:11355109 | lifeskim:mentions | umls-concept:C1522240 | lld:lifeskim |
| pubmed-article:11355109 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:11355109 | lifeskim:mentions | umls-concept:C1883709 | lld:lifeskim |
| pubmed-article:11355109 | pubmed:dateCreated | 2001-5-17 | lld:pubmed |
| pubmed-article:11355109 | pubmed:abstractText | The paper presents the results of experimental studies and clinical trials associated with mechanism underlying nervous system damage and pharmacological interventions to be employed in such processes. Abnormal lipid peroxidation was demonstrated in experimental seizures, epilepsy and cerebral stroke. The authors presented the mechanism of calcium channel blockers activity in epilepsy and their experience in employing such agents in epileptic patients. Results of studies on S-100 protein determinations as a marker of the blood-brain barrier damage in epilepsy and hydrocephalus were discussed, along with the employment of evoked potentials in diagnostic management of headaches and the effects of complex treatment of epilepsy in children using Nootropil. Selected data on experimental valproate encephalopathy were also presented. The authors believe that these studies contribute to the understanding of mechanism that are responsible for nervous system dysfunction, as well as to the evaluation and treatment of their effects. | lld:pubmed |
| pubmed-article:11355109 | pubmed:language | pol | lld:pubmed |
| pubmed-article:11355109 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11355109 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11355109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11355109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11355109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11355109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11355109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11355109 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11355109 | pubmed:issn | 0033-2240 | lld:pubmed |
| pubmed-article:11355109 | pubmed:author | pubmed-author:SobaniecWW | lld:pubmed |
| pubmed-article:11355109 | pubmed:author | pubmed-author:Ku?akWW | lld:pubmed |
| pubmed-article:11355109 | pubmed:author | pubmed-author:SobaniecHH | lld:pubmed |
| pubmed-article:11355109 | pubmed:author | pubmed-author:ArtemowiczBB | lld:pubmed |
| pubmed-article:11355109 | pubmed:author | pubmed-author:Bo?kowskiLL | lld:pubmed |
| pubmed-article:11355109 | pubmed:author | pubmed-author:So?owiejEE | lld:pubmed |
| pubmed-article:11355109 | pubmed:author | pubmed-author:Sobaniec-?oto... | lld:pubmed |
| pubmed-article:11355109 | pubmed:author | pubmed-author:Smigielska-Ku... | lld:pubmed |
| pubmed-article:11355109 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11355109 | pubmed:volume | 58 Suppl 1 | lld:pubmed |
| pubmed-article:11355109 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11355109 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11355109 | pubmed:pagination | 41-7 | lld:pubmed |
| pubmed-article:11355109 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:meshHeading | pubmed-meshheading:11355109... | lld:pubmed |
| pubmed-article:11355109 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11355109 | pubmed:articleTitle | [Studies of damaged processes in the nervous system and possibilities of neuroprotection]. | lld:pubmed |
| pubmed-article:11355109 | pubmed:affiliation | Klinika Neurologii Dzieciecej Akademii Medycznej w Bia?ymstoku. | lld:pubmed |
| pubmed-article:11355109 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11355109 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:11355109 | pubmed:publicationType | Review | lld:pubmed |
